Latest Ivor Royston Stories
SAN DIEGO, April 11, 2011 /PRNewswire/ -- The Board of Biocept, Inc. announced today that David F. Hale has joined the Board as Executive Chairman and Ivor Royston, M.D. as a Director. Mr. Hale and Dr. Royston first worked together at Hybritech, San Diego's first biotech company, of which Dr.
Tracon Pharmaceuticals, a biopharmaceutical company developing targeted therapies for cancer and eye diseases, has appointed Bryan Leigh its new chief medical officer. Dr Leigh has previously served as chief medical officer for Paramount Biosciences.
SAN DIEGO, Sept. 9 /PRNewswire/ -- The Hybritech Reunion Committee today announced the 30th Anniversary Reunion for Hybritech employees will take place on Saturday, September 13th, 2008 at the headquarters of AMN Healthcare in San Diego.
Sidney Kimmel, Founder and Chairman of The Sidney Kimmel Foundation for Cancer Research, has announced the appointment of Theodore Lawrence, M.D., Ph.D. to the Medical Advisory Board of the Kimmel Scholar Award program. Theodore S.
- The act of sweetening by admixture of some saccharine substance.